Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient

Clinical trial NCT03705156 · UNKNOWN

Trial details

NCT number: NCT03705156
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Platinum-sensitive Relapsed Ovarian Cancer

Start date: 2017-06-08
Primary completion: 2020-02-01
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.